Four independent survival studies establish a link between elevated EPOR-expression in myeloma cells and beneficial patient outcome and suggest that EPOR expression can be a novel prognostic marker for newly diagnosed myeloma. The gene discussed is EPOR; the disease is plasma cell myeloma.